Virtus Fund Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
$361K Buy
+19,786
New +$361K ﹤0.01% 387
2014
Q3
Sell
-612
Closed -$12K 2047
2014
Q2
$12K Buy
+612
New +$12K ﹤0.01% 2717